# Blood Volume Dysfunction in ME/CFS - Literature Collection

**Topic:** Hypovolemia, RAAS dysfunction, cardiac dysfunction, endothelial pathology, and RBC dysfunction in ME/CFS
**Date Compiled:** 2026-01-27
**Papers:** 22 total (core: 11, supporting: 11)
**Status:** âœ… BibTeX entries complete, âœ… Appendix updated, ğŸŸ¡ Individual folders partial

---

## Folder Structure

```
blood-volume/
â”œâ”€â”€ RAAS/                          # Renin-Angiotensin-Aldosterone-ADH system
â”‚   â”œâ”€â”€ Miwa_2017_RenninAldosteroneDownregulation/    âœ… COMPLETE
â”‚   â”œâ”€â”€ Raj_2005_RAASParadoxPOTS/                     ğŸŸ¡ Folder created
â”‚   â”œâ”€â”€ Mustafa_2011_AngiotensinPOTS/                 (BibTeX only)
â”‚   â”œâ”€â”€ Stewart_2006_AngIIPOTS/                       ğŸŸ¡ Folder created
â”‚   â”œâ”€â”€ Farquhar_2002_BloodVolumeExercise/            ğŸŸ¡ Folder created
â”‚   â”œâ”€â”€ vanCampen_2018_BloodVolumeOI/                 ğŸŸ¡ Folder created
â”‚   â”œâ”€â”€ Strahler_2013_Catecholamines/                 (BibTeX only)
â”‚   â”œâ”€â”€ Kemp_2019_AutonomicValidation/                (BibTeX only)
â”‚   â””â”€â”€ Gordon_1967_ReninCircadian/                   (BibTeX only)
â”‚
â”œâ”€â”€ natriuretic-peptides/          # BNP and cardiac volumes
â”‚   â”œâ”€â”€ Tomas_2017_BNP/                               ğŸŸ¡ Folder created
â”‚   â””â”€â”€ Newton_2016_CardiacVolumes/                   ğŸŸ¡ Folder created
â”‚
â”œâ”€â”€ capillary-permeability/        # Endothelial dysfunction
â”‚   â”œâ”€â”€ Scherbakov_2020_EndothelialDysfunction/       ğŸŸ¡ Folder created
â”‚   â”œâ”€â”€ Appel_2024_EndothelialReview/                 (BibTeX only)
â”‚   â”œâ”€â”€ Newton_2012_AutonomicSymptoms/                (BibTeX only)
â”‚   â”œâ”€â”€ CastroMarrero_2021_CoQ10NADH/                 (BibTeX only)
â”‚   â”œâ”€â”€ Hornig_2017_CSFCytokines/                     (BibTeX only)
â”‚   â””â”€â”€ Wirth_2023_VascularMCAS/                      (BibTeX only - in Wirth2023)
â”‚
â”œâ”€â”€ erythropoietin/                # RBC function and inflammatory anemia
â”‚   â”œâ”€â”€ Saha_2019_RBCDeformability/                   ğŸŸ¡ Folder created
â”‚   â”œâ”€â”€ Swiatczak_2022_IronMetabolism/                ğŸŸ¡ Folder created
â”‚   â”œâ”€â”€ Winkler_2004_Erythropoietin/                  (BibTeX only)
â”‚   â”œâ”€â”€ Kulapatana_2024_BloodVolumeCO/                (BibTeX only)
â”‚   â”œâ”€â”€ Morceau_2009_CytokineAnemia/                  (BibTeX only)
â”‚   â”œâ”€â”€ McCranor_2014_IL6Erythropoiesis/              (BibTeX only)
â”‚   â””â”€â”€ Fraenkel_2017_AnemiaInflammation/             (BibTeX only)
â”‚
â”œâ”€â”€ SYNTHESIS.md                   # âœ… Integrated mechanistic model
â””â”€â”€ README.md                      # This file
```

---

## Key Findings Summary

### 1. The RAAS Paradox (High Certainty)
- **Finding:** Aldosterone â†“33%, ADH â†“33% despite documented hypovolemia
- **Papers:** Miwa 2017 (n=14), Raj 2005 (n=33)
- **Implication:** Central dysregulation, not peripheral fluid loss

### 2. Plasma Volume Deficit (High Certainty)
- **Finding:** Plasma volume -21% (Raj 2005), -11 ml/kg (van Campen 2018)
- **Measured via:** Dual-isotope blood volume measurement (gold standard)
- **Clinical correlation:** Orthostatic intolerance, exercise capacity

### 3. Cardiac Volume Reduction (High Certainty)
- **Finding:** Reduced end-diastolic and end-systolic volumes
- **Papers:** Newton 2016 (cardiac MRI, n=42)
- **Critical:** NOT due to deconditioning (no correlation with disease duration)

### 4. Endothelial Dysfunction (High Certainty)
- **Finding:** 51% ME/CFS vs 20% controls show peripheral ED
- **Papers:** Scherbakov 2020 (flow-mediated dilation)
- **Link:** Reduced NO bioavailability, tissue hypoperfusion

### 5. RBC Dysfunction (Medium-High Certainty)
- **Finding:** Reduced RBC deformability, inflammatory anemia pattern
- **Papers:** Saha 2019 (deformability), ÅšwiÄ…tczak 2022 (iron sequestration)
- **Mechanism:** IL-6/cytokine-mediated erythropoiesis suppression

---

## Integration Status

### âœ… Completed Tasks

1. **BibTeX entries (22 papers):** All added to `references.bib` with complete metadata
   - DOI, PMID, URLs included
   - Keywords and abstracts where applicable
   - Proper LaTeX formatting verified

2. **Appendix H section:** Comprehensive "Blood Volume and Cardiovascular Dysfunction" added
   - Organized by mechanism (RAAS, cardiac, endothelial, RBC)
   - Integrated mechanistic model included
   - Clinical implications and research gaps noted
   - All 11 core papers cited with detailed summaries

3. **SYNTHESIS.md:** 451-line integrated analysis
   - Causal model with diagram
   - Certainty assessments for each mechanism
   - Subtype considerations
   - Clinical treatment strategies
   - Links to other ME/CFS pathophysiology chapters

4. **Miwa 2017 complete folder:**
   - abstract.txt (full abstract)
   - notes.md (detailed analysis)
   - key-findings.md (main findings and implications)
   - integration-guide.md (87 lines for chapter-integrator agent)
   - README.md (paper summary)

5. **Folder structure:** 9 additional paper folders created (placeholders)

### ğŸŸ¡ Partial Completion

6. **Individual paper folders:** Only Miwa 2017 fully complete
   - Raj 2005 has abstract.txt only
   - Other papers: folders created, awaiting full documentation

### â³ Pending (Next Steps)

7. **Chapter integration:** Use `integration-guide.md` with chapter-integrator agent
   - Add citations to Ch06 (energy metabolism/blood volume section)
   - Add citations to Ch09 (endocrine dysfunction/RAAS section)
   - Add citations to treatment protocols (Ch14b if exists)

8. **Complete remaining folders:** Full documentation for 8 more papers
   - Priority: Raj 2005, Newton 2016, Scherbakov 2020, Saha 2019

9. **PDF downloads:** Attempt to retrieve open-access PDFs
   - Many papers available via PMC (PubMed Central)
   - Miwa 2017: Check ScienceDirect open access
   - Raj 2005: Circulation (may require institutional access)

---

## Certainty Levels by Mechanism

| Mechanism | Certainty | Evidence | Replication | Clinical Use |
|-----------|-----------|----------|-------------|--------------|
| RAAS suppression | **High** | Multiple studies, p<0.01 | âœ… Replicated | Treatment target |
| Plasma volume deficit | **High** | Gold-standard measurement | âœ… Replicated | OI explanation |
| Cardiac volume â†“ | **High** | Cardiac MRI, not deconditioning | Newton 2016 (robust) | Hemodynamic basis |
| Endothelial dysfunction | **High** | FMD, adhesion molecules | âœ… Multiple studies | Perfusion deficit |
| RBC deformability â†“ | **Medium-High** | Novel methodology | Saha 2019 (needs replication) | Oâ‚‚ delivery |
| Inflammatory anemia | **Medium** | Pattern clear, mechanism known | ÅšwiÄ…tczak 2022 + general | Cytokine link |
| Desmopressin efficacy | **Medium** | 50% response rate | Miwa 2017 (small n) | Needs RCT |
| Subtype classification | **Low** | Speculative | No validation studies | Research priority |
| Central dysregulation cause | **Low** | Unknown | N/A | **Urgent gap** |

---

## Clinical Implications

### Diagnostics
- **Tier 1:** CBC, iron panel, ferritin, BMP (standard)
- **Tier 2:** PRA, PAC, ADH, BNP (specialized)
- **Tier 3:** Dual-isotope blood volume, FMD, cytokine panel (research)

### Treatments (Evidence-Based)
1. â†‘ Sodium/fluid intake (10-12g/day, 2-3L)
2. Compression garments
3. Desmopressin (ADH analog) - trial in ADH-deficient subset
4. Fludrocortisone (mineralocorticoid replacement)

### Treatments (Emerging)
5. PAF antagonists (rupatadine) - endothelial + mast cell
6. Antioxidants (CoQ10, Î±-lipoic acid) - endothelial support
7. Immunomodulation (LDN) - cytokine reduction
8. Erythropoiesis support (IV iron in select cases)

### Avoid
- Diuretics (worsen hypovolemia)
- ACE inhibitors (suppress aldosterone further)
- Aggressive exercise (PEM trigger, cytokine spike)

---

## Research Priorities

### Urgent Questions
1. **What causes RAAS/ADH suppression?** (autoimmune? viral? genetic?)
2. **Can we predict treatment responders?** (baseline hormones? genetics?)
3. **Role of capillary permeability?** (plasma leak? mast cell contribution?)

### Studies Needed
4. Longitudinal blood volume tracking
5. PEM-specific measurements (acute volume changes?)
6. Endothelial function intervention trials
7. Responder phenotyping (who benefits from desmopressin/fludrocortisone?)
8. Genetic studies (RAAS/ADH system variants)

---

## Links to Other Pathophysiology

### Energy Metabolism (Ch06)
- Hypovolemia â†’ â†“Oâ‚‚ delivery â†’ mitochondrial ATP deficit
- Tissue hypoperfusion â†’ anaerobic metabolism â†’ lactate accumulation

### Immune Dysfunction (Ch07)
- Cytokines (IL-6, TNF-Î±) â†’ suppressed erythropoiesis
- Immune activation â†’ endothelial activation

### Neurological (Ch08)
- Cerebral hypoperfusion â† â†“cardiac output
- Central dysregulation of RAAS/ADH (hypothalamic?)

### Endocrine (Ch09)
- HPA axis dysfunction â†” RAAS dysregulation
- Possible adrenal insufficiency (low cortisol + low aldosterone)

### PEM (Part 1)
- Exercise â†’ cytokine spike â†’ â†“endothelial function + â†“RBC deformability
- Volume deficit â†’ exercise intolerance (direct mechanism)

---

## Sources

All papers cited in `/home/nicky/code/health-me-cfs/references.bib`.

**Web search sources used during compilation:**
- [Miwa 2017 - PubMed](https://pubmed.ncbi.nlm.nih.gov/27401397/)
- [Raj 2005 - Circulation](https://www.ahajournals.org/doi/10.1161/01.cir.0000160356.97313.5d)
- [Mustafa 2011 - Heart Rhythm PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC3050076/)
- [Stewart 2006 - Clinical Science PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC4511483/)
- [Farquhar 2002 - Am J Physiol-Heart](https://pubmed.ncbi.nlm.nih.gov/11748048/)
- [van Campen 2018 - Front Pediatr](https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2018.00352/full)
- [Tomas 2017 - Open Heart PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC5761285/)
- [Newton 2016 - Open Heart PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC4932290/)
- [Scherbakov 2020 - ESC Heart Failure](https://onlinelibrary.wiley.com/doi/full/10.1002/ehf2.12633)

---

## Usage for Chapter Integrators

### For chapter-integrator agent:
1. Read `integration-guide.md` in each paper folder
2. Follow suggested LaTeX environments and chapter targets
3. Use BibTeX keys from `references.bib`
4. Include certainty assessments as noted

### For readers/researchers:
1. Start with `SYNTHESIS.md` for integrated overview
2. Check Appendix H for detailed summaries of all papers
3. Read individual paper `notes.md` for in-depth analysis
4. Use `key-findings.md` for quick reference

---

**Compiled by:** literature-manager agent
**Date:** 2026-01-27
**Version:** 1.0
**All verifications passed:** âœ…
